comparemela.com

Latest Breaking News On - Juntendo university hospital - Page 2 : comparemela.com

Longeveron Inc Provides Corporate Update and Reports First Quarter 2023 Financial Results

12.05.2023 - - New long-term survival data disclosed from ELPIS I trial of Lomecel-BTM for Hypoplastic Left Heart Syndrome; Data reinforce potential mortality benefit - - First patient dosed in Phase 2 clinical trial of Lomecel-BTM for Aging-Related Frailty .

Longeveron Announces First Patient Dosed in Phase 2 Clinical Trial of Lomecel-B™ for Aging-Related Frailty in Japan

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.